Trial site
Northeast Georgia Medical Center
- 16running trials
- 13closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease5 trials
- Heart failure4 trials
- Prostate cancer3 trials
- Atrial fibrillation2 trials
- Head and neck cancer2 trials
- Stroke2 trials
- Aortic stenosis1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Familial hypercholesterolaemia1 trial
- Follicular lymphoma1 trial
- Liver and biliary tract cancer1 trial
- and 6 more
- Phase
- Phase 313 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed13 trials
- Active, not recruiting12 trials
- Enrolling by invitation2 trials
- Recruiting2 trials
- Lead sponsor
- Abbott Medical Devices4 trials
- Radiation Therapy Oncology Group4 trials
- Eli Lilly and Company3 trials
- ECOG-ACRIN Cancer Research Group2 trials
- Acrivon Therapeutics1 trial
- and 15 more
Running trials
Recruiting
Active, not recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Recruiting
Active, not recruiting
Enrolling by invitation
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis1 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Completed
Validation of the MedHub AutocathFFR Software Device for Non-Invasive Fractional Flow Reserve (FFR)
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Completed
Completed
Completed
Completed
Completed
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Site data: ClinicalTrials.govUpdated 13 Nov 2026